Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)
CNY 33.93
(-0.73%)
CNY 33.93
(-0.73%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 21.15 Billion CNY | 11.84% |
| 2022 | 18.91 Billion CNY | 9.46% |
| 2021 | 17.27 Billion CNY | 4.94% |
| 2020 | 16.46 Billion CNY | -6.65% |
| 2019 | 17.63 Billion CNY | 7.86% |
| 2018 | 16.35 Billion CNY | 43.0% |
| 2017 | 11.43 Billion CNY | 33.49% |
| 2016 | 8.56 Billion CNY | 10.34% |
| 2015 | 7.76 Billion CNY | -3.24% |
| 2014 | 8.02 Billion CNY | 17.45% |
| 2013 | 6.83 Billion CNY | 16.07% |
| 2012 | 5.88 Billion CNY | 14.33% |
| 2011 | 5.14 Billion CNY | 27.85% |
| 2010 | 4.02 Billion CNY | 24.04% |
| 2009 | 3.24 Billion CNY | 23.83% |
| 2008 | 2.62 Billion CNY | 29.18% |
| 2007 | 2.02 Billion CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 5.6 Billion CNY | -8.9% |
| 2024 Q1 | 6.15 Billion CNY | 9.13% |
| 2024 Q3 | 4.88 Billion CNY | -11.52% |
| 2023 Q1 | 5.6 Billion CNY | 10.84% |
| 2023 Q4 | 5.64 Billion CNY | 12.61% |
| 2023 FY | 21.15 Billion CNY | 11.84% |
| 2023 Q3 | 5 Billion CNY | -2.4% |
| 2023 Q2 | 5.13 Billion CNY | -8.38% |
| 2022 Q1 | 4.48 Billion CNY | -2.38% |
| 2022 Q4 | 5.05 Billion CNY | 6.77% |
| 2022 FY | 18.91 Billion CNY | 9.46% |
| 2022 Q3 | 4.73 Billion CNY | 1.97% |
| 2022 Q2 | 4.64 Billion CNY | 3.58% |
| 2021 Q1 | 4.15 Billion CNY | -13.53% |
| 2021 Q3 | 4.45 Billion CNY | 9.13% |
| 2021 Q4 | 4.59 Billion CNY | 3.09% |
| 2021 Q2 | 4.08 Billion CNY | -1.69% |
| 2021 FY | 17.27 Billion CNY | 4.94% |
| 2020 FY | 16.46 Billion CNY | -6.65% |
| 2020 Q2 | 3.69 Billion CNY | 4.41% |
| 2020 Q4 | 4.8 Billion CNY | 8.32% |
| 2020 Q3 | 4.43 Billion CNY | 19.99% |
| 2020 Q1 | 3.53 Billion CNY | -24.38% |
| 2019 Q3 | 4.03 Billion CNY | -12.92% |
| 2019 Q1 | 4.28 Billion CNY | 4.07% |
| 2019 Q2 | 4.63 Billion CNY | 8.08% |
| 2019 FY | 17.63 Billion CNY | 7.86% |
| 2019 Q4 | 4.67 Billion CNY | 15.92% |
| 2018 Q1 | 3.93 Billion CNY | 11.56% |
| 2018 Q4 | 4.11 Billion CNY | -7.19% |
| 2018 Q3 | 4.43 Billion CNY | 15.0% |
| 2018 FY | 16.35 Billion CNY | 43.0% |
| 2018 Q2 | 3.86 Billion CNY | -1.83% |
| 2017 Q2 | 2.5 Billion CNY | 3.02% |
| 2017 FY | 11.43 Billion CNY | 33.49% |
| 2017 Q4 | 3.52 Billion CNY | 18.75% |
| 2017 Q3 | 2.96 Billion CNY | 18.36% |
| 2017 Q1 | 2.43 Billion CNY | 5.24% |
| 2016 Q4 | 2.31 Billion CNY | 7.26% |
| 2016 FY | 8.56 Billion CNY | 10.34% |
| 2016 Q1 | 2 Billion CNY | 3.06% |
| 2016 Q2 | 2.09 Billion CNY | 4.38% |
| 2016 Q3 | 2.15 Billion CNY | 3.08% |
| 2015 Q4 | 1.94 Billion CNY | -1.92% |
| 2015 FY | 7.76 Billion CNY | -3.24% |
| 2015 Q3 | 1.98 Billion CNY | 2.06% |
| 2015 Q2 | 1.94 Billion CNY | 2.66% |
| 2015 Q1 | 1.89 Billion CNY | -7.09% |
| 2014 Q3 | 2.01 Billion CNY | -0.38% |
| 2014 Q1 | 1.94 Billion CNY | 2.01% |
| 2014 FY | 8.02 Billion CNY | 17.45% |
| 2014 Q4 | 2.03 Billion CNY | 0.89% |
| 2014 Q2 | 2.02 Billion CNY | 4.46% |
| 2013 Q2 | 1.72 Billion CNY | 17.7% |
| 2013 Q3 | 1.74 Billion CNY | 1.62% |
| 2013 FY | 6.83 Billion CNY | 16.07% |
| 2013 Q4 | 1.9 Billion CNY | 8.83% |
| 2013 Q1 | 1.46 Billion CNY | -4.59% |
| 2012 Q3 | 1.57 Billion CNY | 2.49% |
| 2012 Q1 | 1.23 Billion CNY | -17.66% |
| 2012 Q4 | 1.53 Billion CNY | -2.95% |
| 2012 Q2 | 1.53 Billion CNY | 24.61% |
| 2012 FY | 5.88 Billion CNY | 14.33% |
| 2011 Q1 | 1.07 Billion CNY | -8.75% |
| 2011 FY | 5.14 Billion CNY | 27.85% |
| 2011 Q4 | 1.5 Billion CNY | 12.37% |
| 2011 Q3 | 1.33 Billion CNY | 8.05% |
| 2011 Q2 | 1.23 Billion CNY | 14.95% |
| 2010 Q3 | 1.06 Billion CNY | 9.17% |
| 2010 Q2 | 972.88 Million CNY | 19.66% |
| 2010 Q1 | 813.01 Million CNY | -9.51% |
| 2010 Q4 | 1.17 Billion CNY | 10.95% |
| 2010 FY | 4.02 Billion CNY | 24.04% |
| 2009 Q4 | 898.51 Million CNY | 2.58% |
| 2009 FY | 3.24 Billion CNY | 23.83% |
| 2009 Q3 | 875.89 Million CNY | 7.75% |
| 2009 Q2 | 812.9 Million CNY | 23.41% |
| 2009 Q1 | 658.67 Million CNY | 0.0% |
| 2008 FY | 2.62 Billion CNY | 29.18% |
| 2007 FY | 2.02 Billion CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 32.05 Billion CNY | 34.01% |
| Zhejiang Zhenyuan Share Co., Ltd. | 4.1 Billion CNY | -415.083% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 656.89 Million CNY | -3119.881% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 737.81 Million CNY | -2766.718% |
| Yifan Pharmaceutical Co., Ltd. | 4.02 Billion CNY | -425.867% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | 533.23 Million CNY | -3866.595% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 895.59 Million CNY | -2261.699% |
| Boai NKY Medical Holdings Ltd. | 1.58 Billion CNY | -1235.794% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 848.19 Million CNY | -2393.686% |